2,3,4,5-tetrahydroxypentanal has been researched along with Kidney Diseases in 2 studies
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
Excerpt | Relevance | Reference |
---|---|---|
"Regarding cancer, MCP modulates several rate-limiting steps of the metastatic cascade." | 2.61 | Pleiotropic Effects of Modified Citrus Pectin. ( Eliaz, I; Raz, A, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eliaz, I | 1 |
Raz, A | 1 |
Martínez-Martínez, E | 1 |
Ibarrola, J | 1 |
Fernández-Celis, A | 1 |
Calvier, L | 1 |
Leroy, C | 1 |
Cachofeiro, V | 1 |
Rossignol, P | 1 |
López-Andrés, N | 1 |
1 review available for 2,3,4,5-tetrahydroxypentanal and Kidney Diseases
Article | Year |
---|---|
Pleiotropic Effects of Modified Citrus Pectin.
Topics: Adipose Tissue; Aortic Valve Stenosis; Blood Proteins; Citrus; Fibrosis; Galectin 3; Galectins; Huma | 2019 |
1 other study available for 2,3,4,5-tetrahydroxypentanal and Kidney Diseases
Article | Year |
---|---|
Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats.
Topics: Actins; Acute Kidney Injury; Acute-Phase Proteins; Albuminuria; Animals; Antigens, CD; beta Catenin; | 2018 |